- A global recovery in stock markets continued this week amid hopes of a resolution to the ongoing trade war after US President Donald Trump claimed a 'great deal' with China could be on the cards.

The FTSE 100 enjoyed gains of 1.3% to 7,128 thanks to rising oil majors BP and Royal Dutch Shell and mining stocks.

BP rallied 3.9% to 567.3p and Shell advanced 3.1% to £25.65, helping to support the index as they are among the biggest in terms of market cap.

European equities were also flying high with Germany's DAX adding 1.6% to 11,467.

On Wall Street, the tech-heavy Nasdaq led the charge, sparking 2.3% to 7,324 around 4:45pm UK time.

Brent crude oil slipped 0.2% to $75.73 per barrel.


Standard Chartered gained 3.1% to 549.5p after the bank posted a 35% increase in third-quarter profit, driven by rising income and falling charges for sour loans.

William Hill added 1.1% to 210.2p as investors applauded its decision to buy online gambling group Mr Green.

Financial services provider Just Group was flat at 89p despite its revenue soaring in the third quarter.

Packaging group Smurfit Kappa advanced 0.5% to £25.66 after it posted a 28% rise in year-to-date earnings and said it would acquire packaging assets in Serbia for €133m.

Fashion retailer Next fell 1.9% to £52.04 amid a slowdown in earnings growth. Computer services provider Computacenter slid 14.2% to £10.78 after it said third-quarter revenue declined owing to weakness in the UK.

Retail property developer Intu Properties shed 1.2% to 196.1p after a firm takeover offer deadline applying to the company's suitors was pushed back by two weeks.

Randgold Resources said it and Barrick Gold had agreed to increase the amount of dividends that investors would get from their proposed merger. Its shares were broadly unmoved at £61.50.


Shares in Defenx soared 57.1% to 11p as investors overlooked a warning on sales in 2018 thanks to news that the business will become cash flow positive during 2019.

Property developer Watkin Jones gained 5.3% to 210p on announcing that it expected to report annual revenue and underlying earnings slightly ahead of its previous expectations.

Immunodiagnostics group Oncimmune Holdings tumbled 21.5% to 95p after it posted a deeper annual loss and cut its revenue expectations for the current year due to the collapse of talks with a potential partner.

Story provided by